Efficacy of rectal indomethacin in prevention of post-operative hyperamylasemia following pancreatoduodenectomy: a randomized controlled trial
- PMID: 38157074
- DOI: 10.1007/s00423-023-03212-9
Efficacy of rectal indomethacin in prevention of post-operative hyperamylasemia following pancreatoduodenectomy: a randomized controlled trial
Abstract
Background: Post-operative hyperamylasemia (POH) following pancreatoduodenectomy (PD) may play a key role in pathogenesis of post-operative pancreatic fistula (POPF). Aim of the current study was to evaluate efficacy of perioperative administration of indomethacin in preventing POH.
Methods: Single-center, double-blind, randomized controlled trial (RCT) conducted on consecutive patients undergoing PD. Patients received either 100 mg of indomethacin per-rectally at induction of anesthesia or standard care. Primary endpoint was incidence of POH in the two arms. POH was defined as postoperative day (POD) 1 serum amylase (S. amylase) levels greater than the upper limit of normal.
Results: After exclusion 44 patients were randomized. The two arms were comparable for preoperative and intraoperative parameters. POH was noted in 20/44 (45.5%) with significantly lower incidence of POH (60.9% vs. 28.6%, p = 0.032) in intervention arm (IA). Median S. amylase, POD 1, 3, and 5 drain amylase, and incidence of clinically relevant POPF (CR-POPF) were lower in IA but failed to reach statistical significance (30.4% vs. 14.3%, p = 0.18). The severity of delayed gastric emptying (DGE) was significantly lower in the IA (grade B/C DGE 23.8% vs. 47.8%, p = 0.023). Evaluation of risk factors for POH showed IA to confer an independent protective effect and increased risk with soft pancreas.
Conclusion: Perioperative per-rectal indomethacin administration is effective in decreasing the incidence of POH following pancreatoduodenectomy.
Keywords: Pancreatoduodenectomy; Post-operative hyperamylasemia; Rectal indomethacin.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Postoperative Serum Hyperamylasemia Adds Sequential Value to the Fistula Risk Score in Predicting Pancreatic Fistula after Pancreatoduodenectomy.Ann Surg. 2023 Aug 1;278(2):e293-e301. doi: 10.1097/SLA.0000000000005629. Epub 2022 Jul 25. Ann Surg. 2023. PMID: 35876366
-
Postoperative serum hyperamylasemia (POH) predicts additional morbidity after pancreatoduodenectomy: It is not all about pancreatic fistula.Surgery. 2022 Aug;172(2):715-722. doi: 10.1016/j.surg.2022.04.003. Epub 2022 May 27. Surgery. 2022. PMID: 35636983
-
Postoperative Hyperamylasemia (POH) Is an Early Predictor of Pancreatic Fistula Occurrence and Severity After Distal Pancreatectomy: Results from a European Multicentric Study.Ann Surg. 2025 Aug 1;282(2):291-298. doi: 10.1097/SLA.0000000000006222. Epub 2024 Feb 2. Ann Surg. 2025. PMID: 38305035
-
Postoperative hyperamylasemia (POH) and acute pancreatitis after pancreatoduodenectomy (POAP): State of the art and systematic review.Surgery. 2021 Feb;169(2):377-387. doi: 10.1016/j.surg.2020.04.062. Epub 2020 Jul 5. Surgery. 2021. PMID: 32641279
-
Systematic review and meta-analysis of surgical drain management after the diagnosis of postoperative pancreatic fistula after pancreaticoduodenectomy: draining-tract-targeted works better than standard management.Langenbecks Arch Surg. 2020 Dec;405(8):1219-1231. doi: 10.1007/s00423-020-02005-8. Epub 2020 Oct 26. Langenbecks Arch Surg. 2020. PMID: 33104886 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources